Search research articles
Contact Us
Filters
Showing results (111-120 of 137) with videos related to
Page
of 14
Sort By:
The New England Journal of Medicine
|
January 16, 1975
L-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings
B Fisher, P Carbone, S G Economou, et al.
JAMA
|
November 17, 2001
Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial
M C King, S Wieand, K Hale, et al.
Journal of the National Cancer Institute
|
December 5, 1998
Adjuvant 5-fluorouracil and leucovorin with or without interferon alfa-2a in colon carcinoma: National Surgical Adjuvant Breast and Bowel Project protocol C-05
N Wolmark, J Bryant, R Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 5, 1999
Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project C-04
N Wolmark, H Rockette, E Mamounas, et al.
Cytometry
|
July 13, 2001
Distinctive patterns of Her-2/neu, c-myc, and cyclin D1 gene amplification by fluorescence in situ hybridization in primary human breast cancers
L E Janocko, K A Brown, C A Smith, et al.
Journal of the National Cancer Institute
|
December 9, 1997
Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer
B Fisher, J Dignam, N Wolmark, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 4, 2019
Prognosis of microsatellite instability and/or mismatch repair deficiency stage III colon cancer patients after disease recurrence following adjuvant treatment: results of an ACCENT pooled analysis of seven studies
J Taieb, Q Shi, L Pederson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 3, 2000
Correlations among p53, Her-2/neu, and ras overexpression and aneuploidy by multiparameter flow cytometry in human breast cancer: evidence for a common phenotypic evolutionary pattern in infiltrating ductal carcinomas
C A Smith, A A Pollice, L P Gu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1997
Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18
B Fisher, A Brown, E Mamounas, et al.
Lancet (London, England)
|
June 22, 1999
Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial
B Fisher, J Dignam, N Wolmark, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 137) with videos related to
Sort By:
Page
of 14
The New England Journal of Medicine
|
January 16, 1975
L-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings
B Fisher, P Carbone, S G Economou, et al.
JAMA
|
November 17, 2001
Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial
M C King, S Wieand, K Hale, et al.
Journal of the National Cancer Institute
|
December 5, 1998
Adjuvant 5-fluorouracil and leucovorin with or without interferon alfa-2a in colon carcinoma: National Surgical Adjuvant Breast and Bowel Project protocol C-05
N Wolmark, J Bryant, R Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 5, 1999
Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project C-04
N Wolmark, H Rockette, E Mamounas, et al.
Cytometry
|
July 13, 2001
Distinctive patterns of Her-2/neu, c-myc, and cyclin D1 gene amplification by fluorescence in situ hybridization in primary human breast cancers
L E Janocko, K A Brown, C A Smith, et al.
Journal of the National Cancer Institute
|
December 9, 1997
Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer
B Fisher, J Dignam, N Wolmark, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 4, 2019
Prognosis of microsatellite instability and/or mismatch repair deficiency stage III colon cancer patients after disease recurrence following adjuvant treatment: results of an ACCENT pooled analysis of seven studies
J Taieb, Q Shi, L Pederson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 3, 2000
Correlations among p53, Her-2/neu, and ras overexpression and aneuploidy by multiparameter flow cytometry in human breast cancer: evidence for a common phenotypic evolutionary pattern in infiltrating ductal carcinomas
C A Smith, A A Pollice, L P Gu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1997
Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18
B Fisher, A Brown, E Mamounas, et al.
Lancet (London, England)
|
June 22, 1999
Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial
B Fisher, J Dignam, N Wolmark, et al.
Page
of 14